Primer: Krsnaa Diagnostics (KRSNAA IN) - Aug 2026
Unique PPP-Focused Business Model: Krsnaa Diagnostics operates primarily through a Public-Private Partnership (PPP) model, providing diagnostic...
94 Views
Thematic Report on India Diagnostics: The Great Consolidation and the Rise of Organized Chains
​Indian diagnostic sector shifts focus from pandemic testing to sustainable growth drivers, with listed players poised to gain market share from...
535 Views
APAC Healthcare Weekly (May 11)- Shionogi, Daiichi Sankyo, HK Inno, Neuren, Biocon, Aster DM, Lupin
Shionogi is acquiring Torii Pharma. Daiichi Sankyo’s Enhertu meets key goal in breast cancer trial. HK inno got domestic approval for P3 trial of...
726 Views
Molbio IPO Review: Point Of Care Medtech - Recovering from Post-COVID Blues
​Molbio's Trunat platform offers WHO-approved portable molecular diagnostics for 30 diseases, with revenue growth despite post-COVID dip and...
111 Views
Krsnaa Diagnostics Q4 & FY25 Update: Strong Margin Expansion Despite Revenue Growth Shortfall
​Krsnaa Diagnostics sees strong margin growth in FY25, driven by operational efficiency and retail expansion, highlighting commitment to profitable...
474 Views